MindBio Therapeutics (XCNQ:MBIO) EV-to-Revenue : 66.27 (As of May. 14, 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, MindBio Therapeutics's enterprise value is C$11.73 Mil. MindBio Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.18 Mil. Therefore, MindBio Therapeutics's EV-to-Revenue for today is 66.27.

The historical rank and industry rank for MindBio Therapeutics's EV-to-Revenue or its related term are showing as below:

XCNQ:MBIO' s EV-to-Revenue Range Over the Past 10 Years
Min: 39.51 Med: 65.82 Max: 77.09
Current: 66.27

During the past 3 years, the highest EV-to-Revenue of MindBio Therapeutics was 77.09. The lowest was 39.51. And the median was 65.82.

XCNQ:MBIO's EV-to-Revenue is ranked worse than
80.33% of 1037 companies
in the Biotechnology industry
Industry Median: 7.95 vs XCNQ:MBIO: 66.27

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-14), MindBio Therapeutics's stock price is C$0.055. MindBio Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00. Therefore, MindBio Therapeutics's PS Ratio for today is 55.00.

MindBio Therapeutics EV-to-Revenue Historical Data

The historical data trend for MindBio Therapeutics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics EV-to-Revenue Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

EV-to-Revenue

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial				-	-	-	-	43.27

Competitive Comparison of MindBio Therapeutics's EV-to-Revenue

For the Biotechnology subindustry, MindBio Therapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindBio Therapeutics's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindBio Therapeutics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where MindBio Therapeutics's EV-to-Revenue falls into.

MindBio Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

MindBio Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	11.730	/	0.177
	=	66.27

MindBio Therapeutics's current Enterprise Value is C$11.73 Mil.
MindBio Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.18 Mil.

MindBio Therapeutics (XCNQ:MBIO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

MindBio Therapeutics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.055	/	0.001
	=	55.00

MindBio Therapeutics's share price for today is C$0.055.
MindBio Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.

MindBio Therapeutics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.